The FDA today issued a public health advisory about reports of a rare brain infection in people using the psoriasis drug Raptiva.
According to the FDA, there have been three confirmed and one possible case of progressive multifocal leukoencephalopathy (PML) in people taking Raptiva; three of those people died.
Psoriasis Drug Raptiva Tied to Brain Infection
A respiratory virus that doesn’t have a vaccine or a specific treatment regimen is spreading...
The Supreme Court on March 2 backed parents' right to be told if their child changes...
